JACC: Cardiooncology

Papers
(The H4-Index of JACC: Cardiooncology is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Full Issue PDF162
Priorities in Cardio-Oncology160
Atrial Fibrillation in Patients With Cancer120
Full Issue PDF101
To Anticoagulate or Not to Anticoagulate to Prevent Arterial Thrombosis During Systemic Cancer Therapy94
Full Issue PDF92
Epigenomics of Cardio-Oncology91
LAG3 Blockade Expands T Cells Within Atherosclerotic Plaque83
Hormonal Therapy and Cardiovascular Health76
Cancer Therapy and Exercise Intolerance: The Heart Is But a Part73
Behaviorally Designed Gamification and Physical Activity Among Breast and Prostate Cancer Survivors72
Deep Inspiration Breath Hold in Left-Sided Breast Radiotherapy71
Cardiovascular Safety in Oncology Clinical Trials70
Prospective Screening for Transthyretin Cardiac Amyloidosis in Spinal Stenosis Surgery Patients63
Balancing Promise and Evidence62
SGLT2i and Primary Prevention of Cancer Therapy–Related Cardiac Dysfunction in Patients With Diabetes61
Moving the Pendulum for Earlier Detection of Systolic and Diastolic Dysfunction in Cancer Survivors58
Full Issue PDF54
Assessing Neurohormonal Antagonist Withdrawal in HER2+ Breast Cancer Patients With CTRCD54
Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma49
Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy48
Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients47
Cardiac Risk Stratification Before Lung Cancer Radiation47
Long-Term, Implantable Event Monitoring of Patients With Wild-Type Transthyretin Cardiac Amyloidosis45
Risk Prediction in Cardio-Oncology: Conceptual and Methodological Considerations43
Proactive Surveillance for ICI Cardiotoxicity42
Incretin Mimetics in Cancer and Cardiovascular Disease41
Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213)38
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms38
Frailty38
Editorial Board/Officers Page38
Cardiac Substructure Radiation Dose and Associations With Tachyarrhythmia and Bradyarrhythmia After Lung Cancer Radiotherapy38
Peripheral Ischemia Fuels Breast Cancer Via Myeloid-Skewed Hematopoiesis36
Cancer Immunotherapy Beyond Checkpoint Blockade36
Atrial Fibrillation After Stem Cell Transplantation36
0.071594953536987